CAS RN: 1252686-51-3
1-[(4R)-4-(1-Methylethyl)-2-thioxo-3-oxazolidinyl]-
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260318
50mg / 250mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1252686-51-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
1252686-51-3 / 1-[(4R)-4-propan-2-yl-2-sulfanylidene-1,3-oxazolidin-3-yl]propan-1-one
Standard CAS: 1252686-51-3
Multi CAS: No
Basic Information
copy
CAS
1252686-51-3 copy
Multi CAS
No copy
Molecular Formula
C9H15NO2S copy
Molecular Weight
201.290000 copy
Exact Mass
201.082350 copy
SMILES
CCC(=O)N1[C@@H](COC1=S)C(C)C copy
InChI
InChI=1S/C9H15NO2S/c1-4-8(11)10-7(6(2)3)5-12-9(10)13/h6-7H,4-5H2,1-3H3/t7-/m0/s1 copy
InChIKey
FIEFJRBGCDTCBC-ZETCQYMHSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
13 copy
Fraction Csp3
0.78 copy
Rotatable bonds
2 copy
H-bond acceptors
3 copy
Molar refractivity
54.31 copy
TPSA
29.54 copy
LogP / Solubility
WLOGP
1.56 copy
MLOGP
1.38 copy
XLogP3
2.1 copy
Consensus LogP
1.68 copy
Log S (ESOL)
-1.94 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-2.34 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.51 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.84 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
2 copy